e2f1 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
e2f1
E2f1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 681 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e2f1/E2F-1+Antibody/bio_rxiv__64898__2026__03__22__713473-71-26-32
Average 96 stars, based on 681 article reviews
E2f1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 681 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e2f1/E2F-1+Antibody/bio_rxiv__64898__2026__03__22__713473-71-26-32
Average 96 stars, based on 681 article reviews
e2f1 - by Bioz Stars,
2026-09
96/100 stars
Images
1) Product Images from "“Targeting LARP1 Enhances Carboplatin Sensitivity and Suppresses Tumor Growth in Endometrial Cancer”"
Article Title: “Targeting LARP1 Enhances Carboplatin Sensitivity and Suppresses Tumor Growth in Endometrial Cancer”
Journal: bioRxiv
doi: 10.64898/2026.03.22.713473
Figure Legend Snippet: (A, B) Kaplan–Meier plot showing that overexpression of E2F1 is associated with shorter overall survival (A) and progression-free interval (B) in endometrial cancer cohort. (C, D) Kaplan–Meier plot showing that co-overexpression of LARP1 and E2F1 is associated with shorter overall survival (C) and progression-free interval (D) in endometrial cancer cohort. (E) Spearman correlation analysis shows a correlation between LARP1 and E2F1 in endometrial cancer patients.
Techniques Used: Over Expression
Figure Legend Snippet: (A, B) Immunoblot analysis showing the protein expression of LARP1 and E2F1 after transfecting ISHI (A) and HEC-1A (B) cells with control or LARP1 siRNA. β-actin was used as a loading control. (C) Images representing immunofluorescence staining of LARP1 (green) and E2F1 (red) in HEC-1A cells after transfection with control or LARP1 siRNA. DAPI was used as a counter stain. Scale bar = 50 µm.
Techniques Used: Western Blot, Expressing, Control, Immunofluorescence, Staining, Transfection
Related Articles
other:Article Title: ATAD2 drives melanoma growth and progression and inhibits ferroptosis Article Snippet: Western Blot:Article Title: Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway Article Snippet: .. The following antibodies were used in immunoblots: β-actin (clone AC-74, Sigma–Aldrich, St. Louis, USA), Article Title: Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Article Snippet: Trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) were purchased from Evidentic GmbH (Potsdam, Germany). .. The following antibodies were used for immunoblotting: total CDK7 (Cell Signaling Technology, Danvers, MA, USA, 2090S, RRID: AB_2077140), MYC (Cell Signaling Technology, 13987, RRID: AB_2631168), Ubiquitin Proteomics:Article Title: Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Article Snippet: Trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) were purchased from Evidentic GmbH (Potsdam, Germany). .. The following antibodies were used for immunoblotting: total CDK7 (Cell Signaling Technology, Danvers, MA, USA, 2090S, RRID: AB_2077140), MYC (Cell Signaling Technology, 13987, RRID: AB_2631168), Affinity Purification:Article Title: Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Article Snippet: Trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) were purchased from Evidentic GmbH (Potsdam, Germany). .. The following antibodies were used for immunoblotting: total CDK7 (Cell Signaling Technology, Danvers, MA, USA, 2090S, RRID: AB_2077140), MYC (Cell Signaling Technology, 13987, RRID: AB_2631168), Blocking Assay:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Incubation:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Article Title: “Targeting LARP1 Enhances Carboplatin Sensitivity and Suppresses Tumor Growth in Endometrial Cancer” Article Snippet: .. Cells were then incubated overnight at 4 °C with the following primary antibodies: LARP1 (Cat. No. sc-515873; 1:200 dilution; Santa Cruz Biotechnology, Dallas, TX, USA) and Control:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Saline:Article Title: The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes Article Snippet: Blots were stained with 0.5% Ponceau S (Sigma P3504, St. Louis, MO, USA) to ensure equal loading. .. The blots were blocked in 5% non-fat milk (Meijer, Tipp City, OH, USA) in TBST (Tris-buffered saline containing 0.1% Tween-20) and then probed overnight with primary antibodies from Cell Signaling Technology (Danvers, MA, USA) recognizing |
